FDA Panel backs booster shot for Pfizer vaccine

The Covid-19 vaccine booster shot proposed by Pfizer Inc. and BioNTech SE should be given to older Americans and those at high risk, a panel of expert advisers to the U.S. Food and Drug Administration said, rejecting a request for broader distribution. [“Older” includes me]

While the recommendation isn’t binding, it’s a blow to the Biden administration’s plan to deliver third doses to all American adults in the coming weeks to stave off the virus’s spread. The FDA will have to decide in the coming days whether to follow suit or overrule its trusted scientific advisers and proceed with a broader booster authorization.

Pfizer had originally proposed approving a booster shot for everyone 16 and older. But the advisers rejected that idea out of concern that the data to support such a broad application was thin and there could be risks, especially for younger people.

No worries for me. Anytime I’ve had a bad reaction to treatment or vaccination, it usually showed up early. Penicillin in the first case. Shingles vaccine in the second category. Near as I can recall, never had a bad reaction to any other medication or vaccine.